Hikma Pharmaceuticals Share Discussion Threads

[montyhedge] 19/10/2021 09:04

I think trading update due around first week of November, last year 7th November.

[montyhedge] 12/10/2021 12:26

Article with Hikma in there, one to BUY its says.

[montyhedge] 12/10/2021 09:02

Seems oversold recently.

[robertball] 05/10/2021 16:27

Inhaler problems? Re: greenhouse gases

[montyhedge] 29/9/2021 15:51

One little thing pound weak, good for Hikma profits.

[montyhedge] 29/9/2021 15:34

Looking at this latest deal, it's looks quite good for Hikma.

[montyhedge] 27/9/2021 08:14

Yes seem very smart management, another deal announced today.
Surprised the shares not higher.

Also looking back I think its been 15 years of continuous dividend growth, plus couple of specials.

[robertball] 26/9/2021 19:35

It's a bit of a weird company. Jordanian run but the ex Teva CEO is excellent. I attended the last AGM and it was weird - just 4 directors in on a zoom call. All over in 10Minutes. I wish I had submitted a question now.

[montyhedge] 24/9/2021 10:12

Hikma shows up on the RSI index oversold index today. I agree with that, oversold.

[montyhedge] 23/9/2021 08:39

Yes the news they have made last couple of months regarding new deals etc, have gone under the radar of investors, I suppose they like the know names like GSK, Astra.But the growth in Hikma my opinion.

[robertball] 22/9/2021 07:26

Indeed. It'll catch up on trading update?

[montyhedge] 21/9/2021 12:27

Another nice deal, does not get reflected in the shareprice. Hikma misses rise in pharma stocks once again.

[boadicea] 20/9/2021 19:51

After hours news -

[robertball] 20/9/2021 17:06

Same here. Natural hedge

[montyhedge] 20/9/2021 16:21

If the market crashes, pharma's and gold miners normally do ok. Surprised Hikma been hit so hard.

[montyhedge] 06/9/2021 12:46

To me Hikma flys below the radar of a lot of investors, they all know GSK, Astra etc, but Hikma seems not so many. I think lot more potential than GSK in shareprice growth.Low p.e I think this will double in shareprice coming years.GSK shareprice below what it was 25 years ago.

[montyhedge] 06/9/2021 12:42

This will certainly give shareprice a boost.

[robertball] 04/9/2021 17:03

Stelara had annual sales of $7.7bn in 2020

[18bt] 02/9/2021 08:25

That's the trouble with a RNSNON - some like me miss it!

[montyhedge] 02/9/2021 08:23

The rns on the 27th August could be superb, think investors are ignoring that one.

[montyhedge] 26/8/2021 15:08

Nothing to go for short term, gone ex div, so will just drift until a positive rns.

[montyhedge] 24/8/2021 15:00

Gone ex div, so I suppose some selling.

[montyhedge] 17/8/2021 12:02

Some hefty buys coming in, 10,000 shares just bought, thats 255,000 pounds.

Looks like the smart money coming in, with the size of trades.

[montyhedge] 17/8/2021 11:24

Looks like their are right.

[montyhedge] 12/8/2021 10:52

Robert
Not just for that division, they look a sitting duck from another pharma company for all their products.